Evidence map›Paper›PMID 40453158›Full record

ArticleIranian journal of otorhinolaryngology2025

Assessing the Role of Inflammatory Markers in Predicting Central Lymph Node Metastasis in Papillary Thyroid Carcinoma.

Ebrahim Farashi, Sajjad Ranjbar, Sahand Eslami, Nikzad Shahidi, Seyed Ziaeddin Rasihashemi

Abstract read
In one paragraph

Article in Iranian journal of otorhinolaryngology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ebrahim FarashiDepartment of Otorhinolaryngology-Head and Neck Surgery, Tabriz University of Medical Sciences, Tabriz, Iran.
Sajjad RanjbarDepartment of Otorhinolaryngology-Head and Neck Surgery, Tabriz University of Medical Sciences, Tabriz, Iran.
Sahand EslamiDepartment of Pediatric Surgery, Tabriz University of Medical Sciences, Tabriz, Iran.
Nikzad ShahidiDepartment of Otorhinolaryngology-Head and Neck Surgery, Tabriz University of Medical Sciences, Tabriz, Iran.
Seyed Ziaeddin RasihashemiDepartment of Cardiothoracic Surgery, Tabriz University of Medical Sciences, Tabriz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The current study sought to assess the predictive value of inflammatory markers, namely the platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR), in relation to central lymph node metastasis (CLNM) in patients with papillary thyroid carcinoma (PTC). Materials and Methods: A total of 79 participants with confirmed PTC diagnosis following surgery were included in the study. Demographic data, clinical characteristics, and laboratory variables were collected. CLNM was evaluated based on pathological findings. NLR and PLR were calculated to assess their associations with clinicopathological features and metastasis. Results: The study included 26 males (25.9%) and 53 females (74.1%), with a mean age of 42.26 years (range 15-74). Significant findings included a higher incidence of CLNM in males ( Conclusion: This study demonstrates significant associations between clinicopathological features and CLNM in PTC. Male gender, larger tumor size, and multifocality correlated with higher CLNM rates. While inflammatory markers such as NLR and PLR did not show significant differences, PLR's positive correlation with age in CLNM patients suggests potential prognostic value, warranting further investigation.

Indexed as

Lymph NodeNLRPapillary Thyroid CarcinomaPLRThyroid Nodule

Identifiers

PMID40453158
PMCPMC12126203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.